Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of Ticagrelor on the Inflammatory Response to Human Endotoxemia
NCT02612480Completed
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ticagrelor in endotoxemia (4 arms), sponsored by Radboud University Medical Center. Primary endpoint: Plasma TNF-alpha concentration at day 7. Started Oct 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
endotoxemia
Beyond the preview
Go deeper on NCT02612480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02612480.